Consolidated Statement of Cash Flows (Unaudited) $ in Thousands	3 Months Ended
	Mar. 31, 2025 USD ($)
Operating activities
Net increase/(decrease) in net assets resulting from operations	$ 8,784
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(226)
Net change in unrealized (gain) loss on investments	(9,286)
Payments to purchase investments	(521,434)
Proceeds from sale of investments	246,138
Net (increase) decrease on derivatives	(30,920)
Changes in operating assets and liabilities:
(Increase)/decrease in due from Operating Manager	(1,509)
(Increase)/decrease in interest receivable	(2,694)
(Increase)/decrease in deferred offering expenses	159
(Increase)/decrease in dividends receivable	(1,007)
(Increase)/decrease in receivable for investments sold	(18)
(Increase)/decrease in prepaid expenses and other assets	(12,111)
Increase/(decrease) in payable for investments purchased	17,763
Increase/(decrease) in due to Operating Manager	1,323
Increase/(decrease) in interest payable	1,659
Increase/(decrease) in performance fees payable	731
Increase/(decrease) management fees payable	370
Increase/(decrease) in other accrued expenses and liabilities	1,051
Net cash provided by (used in) operating activities	(301,227)
Financing activities
Notes Borrowings	30,124
Proceeds from issuance of shares, net of change in capital subscriptions receivable	230,944
Redemption of shares, net of change in redemptions payable	(9,137)
Distributions declared, net of change in distributions payable	(4,031)
Net cash provided by (used in) financing activities	247,900
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	(53,327)
Cash and cash equivalents at beginning of period	58,587
Cash and cash equivalents at end of period	5,260
Series I
Operating activities
Net increase/(decrease) in net assets resulting from operations	1,663
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(52)
Net change in unrealized (gain) loss on investments	(2,344)
Payments to purchase investments	(110,776)
Proceeds from sale of investments	56,329
Net (increase) decrease on derivatives	(6,830)
Changes in operating assets and liabilities:
(Increase)/decrease in due from Operating Manager	(44)
(Increase)/decrease in interest receivable	(556)
(Increase)/decrease in deferred offering expenses	183
(Increase)/decrease in dividends receivable	(240)
(Increase)/decrease in receivable for investments sold	(3)
(Increase)/decrease in prepaid expenses and other assets	(2,740)
Increase/(decrease) in payable for investments purchased	3,986
Increase/(decrease) in due to Operating Manager	(66)
Increase/(decrease) in interest payable	408
Increase/(decrease) in performance fees payable	195
Increase/(decrease) management fees payable	105
Increase/(decrease) in other accrued expenses and liabilities	1,121
Net cash provided by (used in) operating activities	(59,661)
Financing activities
Notes Borrowings	7,188
Proceeds from issuance of shares, net of change in capital subscriptions receivable	47,389
Redemption of shares, net of change in redemptions payable	(8,563)
Distributions declared, net of change in distributions payable	(741)
Net cash provided by (used in) financing activities	45,273
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	(14,388)
Cash and cash equivalents at beginning of period	16,817
Cash and cash equivalents at end of period	2,429
Series II
Operating activities
Net increase/(decrease) in net assets resulting from operations	7,121
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(174)
Net change in unrealized (gain) loss on investments	(6,942)
Payments to purchase investments	(410,658)
Proceeds from sale of investments	189,809
Net (increase) decrease on derivatives	(24,090)
Changes in operating assets and liabilities:
(Increase)/decrease in due from Operating Manager	(1,465)
(Increase)/decrease in interest receivable	(2,138)
(Increase)/decrease in deferred offering expenses	(24)
(Increase)/decrease in dividends receivable	(767)
(Increase)/decrease in receivable for investments sold	(15)
(Increase)/decrease in prepaid expenses and other assets	(9,371)
Increase/(decrease) in payable for investments purchased	13,777
Increase/(decrease) in due to Operating Manager	1,389
Increase/(decrease) in interest payable	1,251
Increase/(decrease) in performance fees payable	536
Increase/(decrease) management fees payable	265
Increase/(decrease) in other accrued expenses and liabilities	(70)
Net cash provided by (used in) operating activities	(241,566)
Financing activities
Notes Borrowings	22,936
Proceeds from issuance of shares, net of change in capital subscriptions receivable	183,555
Redemption of shares, net of change in redemptions payable	(574)
Distributions declared, net of change in distributions payable	(3,290)
Net cash provided by (used in) financing activities	202,627
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	(38,939)
Cash and cash equivalents at beginning of period	41,770
Cash and cash equivalents at end of period	$ 2,831